SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.09.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.09.22 | Roche Hold | Deutsche Bank AG | |
| 13.09.22 | Roche Outperform | Bernstein Research | |
| 12.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 12.09.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 09.09.22 | Roche Hold | Deutsche Bank AG | |
| 08.09.22 | Roche Buy | Jefferies & Company Inc. | |
| 31.08.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 26.08.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.08.22 | Novartis Neutral | UBS AG | |
| 25.08.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 11.08.22 | Roche Hold | Deutsche Bank AG | |
| 10.08.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 26.07.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.07.22 | Roche Neutral | Credit Suisse Group | |
| 25.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 22.07.22 | Roche Hold | Deutsche Bank AG | |
| 21.07.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.07.22 | Roche Neutral | UBS AG | |
| 21.07.22 | Roche Outperform | Bernstein Research | |
| 21.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 20.07.22 | Novartis Neutral | Credit Suisse Group | |
| 20.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.07.22 | Roche Hold | Deutsche Bank AG | |
| 20.07.22 | Novartis Sell | Deutsche Bank AG | |
| 19.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 19.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 19.07.22 | Novartis Neutral | UBS AG | |
| 19.07.22 | Novartis Buy | Jefferies & Company Inc. | |
| 18.07.22 | Novartis Underweight | Barclays Capital | |
| 18.07.22 | Roche Overweight | Barclays Capital | |
| 18.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 15.07.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 14.07.22 | Roche Hold | Deutsche Bank AG | |
| 13.07.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 13.07.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.07.22 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.07.22 | Roche Neutral | UBS AG |